World Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

World Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2M	Sell	11,631 -328	-3%	-$56.4K	0.03%	477
2026 Q1	$2.02M	Buy	11,959 +106	+0.9%	+$18.1K	0.03%	481
2025 Q4	$2M	Buy	11,853 +3,973	+50%	+$645K	0.03%	469
2025 Q3	$1.14M	Buy	7,880 +196	+3%	+$26.8K	0.02%	531
2025 Q2	$972K	Buy	7,684 +721	+10%	+$88.5K	0.02%	530
2025 Q1	$891K	Sell	6,963 -44	-0.6%	-$5.97K	0.02%	540
2024 Q4	$926K	Buy	7,007 +4,743	+209%	+$667K	0.03%	492
2024 Q3	$330K	Buy	2,264 +13	+0.6%	+$1.88K	0.01%	710
2024 Q2	$309K	Buy	+2,251	New	+$300K	0.02%	492

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

World Investment Advisors's IBB Position: Q2 2026 in Review

World Investment Advisors reduced its iShares Biotechnology ETF (IBB) stake by 2.7% in Q2 2026, selling an estimated $56.4K and leaving 11,631 shares worth $2M. The position accounts for 0.03% of the portfolio, ranked #477.

World Investment Advisors first reported a position in IBB in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.02M in Q1 2026. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

World Investment Advisors held 11,631 shares of iShares Biotechnology ETF worth $2M as of Q2 2026.
World Investment Advisors sold 328 iShares Biotechnology ETF shares in Q2 2026, an estimated $56.4K.
iShares Biotechnology ETF made up 0.03% of World Investment Advisors's portfolio in Q2 2026, its #477 holding.
World Investment Advisors first reported a position in iShares Biotechnology ETF in Q2 2024 and has held it in 9 quarters since.
World Investment Advisors's iShares Biotechnology ETF position peaked at $2.02M in Q1 2026.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.